Blood pressure medicines
Yes. Losartan is a blood pressure medicine, and one of the most prescribed drugs on the planet. It belongs to a class called angiotensin II receptor blockers, shortened to ARBs, and you can identify every member of the family by the last four letters of its name: losartan, valsartan, irbesartan, candesartan, telmisartan, olmesartan. Losartan arrived first, in 1995. It brings pressure down by blocking the receptor that a hormone called angiotensin II uses to squeeze arteries narrow. Receptor blocked, artery relaxed, pressure down, in the top number, the bottom number, and the mean arterial pressure those two numbers average out into.
Underneath that question sits a better one. Losartan gets confused with lisinopril constantly, because doctors move patients between the two so often that patients assume they are the same thing. They are not the same thing. Both act on the same hormone system, and they interrupt it at different points, and that single structural difference explains the dry cough, the switch, and a large share of the confusion that surrounds lisinopril and the ACE inhibitor class.
So this piece answers the question directly, then lays out the ARB versus ACE inhibitor comparison properly, because that is the decision sitting behind your prescription. Valsartan gets equal billing throughout.
Losartan at a glance
Before the mechanism, the practical shape of the drug. This table covers what people search for in the first thirty seconds, and the rest of the article explains why each line says what it says.
| Question | Answer |
|---|---|
| Is it a blood pressure pill? | Yes. Licensed for high blood pressure, and also used to protect the kidneys in type 2 diabetes and to reduce stroke risk in people with a thickened heart muscle. |
| Drug class | Angiotensin II receptor blocker (ARB). Not an ACE inhibitor, not a beta blocker like metoprolol, not a calcium channel blocker like amlodipine. |
| What it blocks | The AT1 receptor, the docking point angiotensin II uses to constrict blood vessels and trigger salt retention. |
| Typical drop | Class average sits in the region of 8 to 12 mmHg systolic and 4 to 6 mmHg diastolic, larger in people who start higher. |
| First effect | Measurable within about six hours of the first dose. |
| Full effect | Three to six weeks. Judging it in three days is the most common error. |
| Dry cough | Roughly the same rate as a dummy pill. This is the headline difference from ACE inhibitors. |
| Blood test needed | Yes. Potassium and kidney function, usually a week or two after starting and after any dose change. |
| Pregnancy | Contraindicated in every trimester. Same rule as ACE inhibitors, no exceptions. |
| Unusual property | Losartan lowers uric acid slightly. It is the only ARB with a meaningful effect of that kind. |
Two things in that table drive everything else. The cough line is why so many prescriptions get switched from an ACE inhibitor to losartan in the first place. The three to six week line is why people conclude the drug has failed when it has barely started, then go looking at which blood pressure drugs are prescribed most often to find a replacement they do not need. Both get full sections below.
Read this before anything else
ARBs and ACE inhibitors must not be taken in pregnancy, at any stage. Both classes damage the developing kidneys and can be fatal to a fetus. If you are pregnant, planning a pregnancy, or find out you are pregnant while taking losartan or valsartan, contact your doctor straight away so the prescription can be changed to something safe. Do not simply stop and wait.
The potassium risk is identical across the two classes. Losartan raises blood potassium, and combining it with potassium supplements, potassium-sparing diuretics such as spironolactone or amiloride, or a potassium-based salt substitute can push potassium high enough to disturb heart rhythm. Severe hyperkalemia can be silent until it is dangerous.
An ACE inhibitor and an ARB should not normally be taken together. Dual blockade was tested properly in a large trial and it produced no extra benefit alongside more low blood pressure, more kidney injury and more hyperkalemia. If both appear on your medication list, ask your pharmacist to check it.
Angioedema, the deep swelling of lips, tongue or throat, is far rarer with ARBs than with ACE inhibitors, and it is not impossible. Swelling of the tongue, lips or throat, or any difficulty breathing or swallowing, is an emergency. Call emergency services, do not drive yourself.
Over the counter medicines interact more than people expect. Ibuprofen and its relatives blunt ARBs, and an NSAID taken alongside an ARB and a diuretic markedly raises the risk of sudden kidney injury.
Track the effect, not the anecdote
A drug that takes six weeks to reach full effect cannot be judged from one reading. Log a morning and evening number for two weeks and put the averages through the mean arterial pressure calculator so you can see the trend that single readings hide.
What this article covers
How losartan lowers blood pressure
Your kidneys hold a permanent opinion about your blood pressure. When they sense that the blood arriving is under-pressured, or short of sodium, or that the nervous system is shouting at them, they release an enzyme called renin. That release starts a short chemical chain, and the end product of the chain is one of the most powerful vessel-tightening molecules the body makes.
angiotensinogen (made by the liver) + renin (from the kidney) = angiotensin Iangiotensin I + ACE (the converting enzyme, mostly in the vessel lining) = angiotensin IIangiotensin II locks onto the AT1 receptor = arteries narrow, aldosterone rises, salt and water stay inlosartan sits on the AT1 receptor so angiotensin II cannot dock thereThat chain is the renin-angiotensin system, and it exists for good reasons. It is what stops your pressure collapsing when you lose blood or go a day without salt. The trouble is that it stays switched on in a great many people whose pressure is already too high, and once it does, every one of its actions works against you. Angiotensin II narrows arteries directly. It orders the adrenal glands to release aldosterone, which tells the kidney to hold on to sodium, and held sodium holds water, and retained water raises the volume the heart has to push. Over years it also drives thickening of the heart wall and stiffening of vessel walls. The reason kidney function and blood pressure are so tightly linked is that this system runs through the kidney at both ends.
Losartan interrupts the last step. Angiotensin II still gets made, in normal quantities and even slightly higher ones, and it circulates with nowhere useful to go, because the AT1 receptor it needs is occupied. Blocked receptor means the vasoconstriction signal never lands. Arteries widen back toward their resting diameter, aldosterone output falls, sodium leaves rather than staying, and the pressure inside the system drops.
There is a second-order effect that gets less attention. Angiotensin II also binds a different receptor, AT2, which does roughly the opposite job: mild vasodilation and a signal against tissue scarring. Because an ARB blocks only AT1, all that spare angiotensin II drifts toward AT2 instead. Whether this contributes much in practice is still argued over, and it is one of the theoretical arguments in favor of the class.
The size of the effect is worth having in front of you. Across the class, ARBs bring systolic pressure down by something like 8 to 12 mmHg and diastolic by 4 to 6 mmHg, averaged over trial populations. Averages hide a lot. Someone starting at 168/102 usually loses far more than someone starting at 138/86, because these drugs push hardest when the system they block is most active. People on a high-sodium diet often respond less until the salt comes down, which is one of the reasons sodium intake changes how much medication you need and why a low dose thiazide diuretic pairs so well with an ARB.
Take a real pair of numbers. Someone reading 152/94 at home, before treatment, has a pulse pressure of 58 and a mean arterial pressure a good way above where you want to sit.
MAP = diastolic + (systolic-diastolic)/3Before: 94 + (152-94)/3 = 94 + 19.3 = 113.3 mmHgAfter six weeks at 134/84: 84 + (134-84)/3 = 84 + 16.7 = 100.7 mmHgA drop of roughly 13 mmHg in the mean is a real change in the load on every artery in the body, and it is invisible if you only glance at the top number. Normal mean arterial pressure runs somewhere around 70 to 100 mmHg, and 60 is the rough floor below which organs stop being reliably perfused. If you want to see what your own numbers do over a course of treatment, working out the mean from a systolic and diastolic pair takes ten seconds and tells you more than either number alone.
Losartan will not drive a normal pressure into the basement. Its effect scales with how overactive the system is, so a reading around 120/80 does not collapse to 100/60 on an ARB, though dehydration, a strong diuretic or frailty can each push someone lower than intended.
ARBs versus ACE inhibitors: same system, two different doors
This is the comparison that matters, and it is the one people almost never get explained to them at the pharmacy counter. Both classes attack the renin-angiotensin system. They hit it at different points, and the difference is not academic. It determines who coughs, who swells, and who ends up switched from one drug to the other after three months of misery.
An ACE inhibitor such as lisinopril, ramipril or enalapril blocks the converting enzyme itself. Angiotensin I piles up, angiotensin II is never made in normal amounts, and the whole downstream cascade quietens. An ARB such as losartan or valsartan leaves the enzyme alone and blocks the receptor at the far end. Angiotensin II gets made and then finds the lock changed.
Now the important part. The converting enzyme has a second job that has nothing to do with blood pressure. It also breaks down bradykinin, an inflammatory peptide, along with substance P. Inhibit the enzyme and you do not only stop angiotensin II production, you also stop bradykinin being cleared. Bradykinin accumulates in airway tissue, irritates the cough receptors there, and produces the dry, tickly, unproductive cough that ACE inhibitors are famous for. It is not a chest infection and it does not respond to cough syrup. It stops when the drug stops, sometimes taking several weeks to fade.
How common is it? Published figures scatter widely, from about 5% to around 20%, with roughly one in ten being the number most clinicians carry in their heads. It runs higher in women and considerably higher in people of East Asian ancestry. ARBs do not touch the converting enzyme, so bradykinin clearance carries on as normal, and in trials the cough rate on an ARB sits at about the level of the dummy pill. That is the whole reason the switch from lisinopril to losartan is one of the most routine moves in general practice.
| Feature | ACE inhibitors (lisinopril, ramipril, enalapril) | ARBs (losartan, valsartan, candesartan) |
|---|---|---|
| Where they act | Block the enzyme that manufactures angiotensin II | Block the receptor angiotensin II acts on |
| Angiotensin II levels | Fall | Stay normal or rise, with the receptor blocked |
| Bradykinin | Accumulates, since the same enzyme clears it | Unaffected |
| Dry cough | Common. Around one in ten, higher in some groups | Placebo-level |
| Angioedema | Rare but the main serious class risk | Rarer still, though not zero |
| Blood pressure lowering | Broadly the same as ARBs at equivalent doses | Broadly the same as ACE inhibitors |
| Cardiovascular outcomes | Similar across head-to-head evidence | Similar across head-to-head evidence |
| Potassium | Rises | Rises, to the same degree |
| Kidney function | Small creatinine rise expected on starting | Small creatinine rise expected on starting |
| Pregnancy | Contraindicated, all trimesters | Contraindicated, all trimesters |
| People stopping the drug | Higher, mostly because of cough | Lower. The class is better tolerated |
| Cost | Generic and cheap | Generic and cheap, historically the pricier of the two |
| Escape routes | Other enzymes such as chymase can still make angiotensin II | Receptor blockade holds however the hormone was made |
Angioedema deserves its own paragraph, because it is the one class effect that can kill. It is a deep swelling of the lips, tongue, floor of the mouth or throat, driven by the same bradykinin build-up that causes the cough, and it can appear after the first dose or after nine uneventful years on the same tablet. It is uncommon with ACE inhibitors, well under one in a hundred, and it occurs more often in Black patients. With ARBs it is rarer again, and the honest position is that it still happens. People who had angioedema on an ACE inhibitor carry a small carry-over risk when moved to an ARB, which is why that particular switch is made with more care than the switch made for a cough.
The last row of the table is the one clinicians argue about. Other enzymes, chymase in particular, can build angiotensin II by an alternative route, especially in heart and vessel tissue, so an ACE inhibitor never achieves total blockade. An ARB sidesteps that by guarding the receptor whichever factory the hormone came from. On paper it is a real advantage. In outcome trials it has never produced a clear survival edge.
None of this makes losartan a superior drug to lisinopril. It makes it a different drug with a different side effect profile at the same job, and a great many people do perfectly well on either. If your ACE inhibitor causes no cough, there is no reason to leave it. The switch exists for people who cannot tolerate one, and for people in whom the cough is misread as asthma, reflux or a lingering virus for months before anyone connects it to the tablet. Dizziness on blood pressure medication gets attributed to the drug immediately. A cough almost never does.
Does one work better than the other?
Here is where honest reporting matters more than a tidy answer. On blood pressure lowering, the two classes are close to interchangeable. Meta-analyses comparing them at equivalent doses find differences of a millimeter or two, well inside the noise of home monitoring. If you swapped every ACE inhibitor prescription in a country for an ARB tomorrow, average national blood pressure would barely move.
On hard outcomes, the picture is much the same. The largest direct comparison enrolled more than twenty-five thousand people at high cardiovascular risk and set an ARB against an ACE inhibitor head to head, with a third arm taking both. The ARB matched the ACE inhibitor on the combined rate of cardiovascular death, heart attack, stroke and hospital admission for heart failure. The combination arm did no better than either drug alone and produced clearly more harm: more symptomatic low blood pressure, more fainting, more kidney impairment, more hyperkalemia. That trial is the reason the two classes are not stacked together outside specialist situations.
Losartan has its own landmark study, in people with high blood pressure and a thickened left ventricle, where it beat a beta blocker comparator on stroke prevention at matched blood pressure. That result says something about losartan against an older drug. It says nothing about losartan against ramipril.
Where the classes separate is tolerability, and that separation is consistent. Fewer people abandon an ARB. Large real-world analyses of first-time prescriptions have found similar cardiovascular event rates with meaningfully fewer adverse events on ARBs, mostly cough and angioedema. Guidelines have responded by listing ACE inhibitors and ARBs side by side as first-line options, with no preference stated between them, alongside calcium channel blockers and thiazide-type diuretics. Your prescriber picks on the details of you: your kidney numbers, your potassium, whether you have diabetes with protein in the urine, what your insurance or pharmacy charges, and what you have already failed on.
A few situations do tilt the choice. Heart failure with a weak pumping chamber has decades of ACE inhibitor evidence behind it, and ARBs are the accepted substitute for people who cannot take one. In diabetic kidney disease with protein leaking into the urine, both classes protect the kidney and either is reasonable. If a patient has gout, losartan specifically has a small extra argument in its favor, covered further down. And if a cough has already driven someone off one ACE inhibitor, moving them to a second ACE inhibitor rarely helps, since the mechanism is shared across the class.
So there is no winner to declare. Two families, the same target, similar results, different reasons to stop taking them. Anyone weighing up options across the whole field should read the overview of the main blood pressure drug classes and the honest version of what lifestyle change can and cannot achieve on its own before deciding a particular tablet has let them down.
The sartan family, and where valsartan fits
Every ARB ends in the same syllable, which makes this the easiest drug class in the pharmacy to recognize. They share the mechanism and differ in duration, dosing and a handful of quirks.
| Drug | Duration and dosing | Distinguishing feature |
|---|---|---|
| Losartan | Shortest acting of the group. Sometimes split into two daily doses when one leaves the last hours of the day uncovered. | Converted in the liver to a more potent active metabolite. Lowers uric acid. |
| Valsartan | Once daily for the great majority of people. | Heavily studied in heart failure and after a heart attack. Half of the combination pill used in modern heart failure care. |
| Candesartan | Long acting, once daily, tight 24-hour cover. | Binds the receptor very firmly. Also used for migraine prevention off-label. |
| Irbesartan | Once daily. | Strong evidence base in diabetic kidney disease. |
| Telmisartan | Longest half-life in the class, comfortably once daily. | The ARB tested head to head against an ACE inhibitor in the large outcome trial. |
| Olmesartan | Once daily. | Associated with a rare severe diarrhea syndrome that resolves on stopping. |
Valsartan attracts almost as many questions as losartan, so take them directly. Does valsartan lower blood pressure? Yes, by exactly the same route: it blocks the AT1 receptor and the vessel-narrowing signal never arrives. Is valsartan a good blood pressure medicine? It is a well-established one, with a larger heart failure evidence base than losartan and a longer duration of action, and no ARB has been shown to beat the others on blood pressure lowering by any margin that would matter to you. The practical difference between losartan and valsartan is mostly the length of cover across 24 hours and what your pharmacy stocks.
One trial set valsartan against amlodipine in high-risk hypertension. The calcium channel blocker dropped pressure faster early on, the main outcome came out similar across the full run, and each drug carried its own trade-offs. The lesson buried in it is that getting pressure down early counts, whichever family does the work.
If your prescription reads losartan potassium, that is simply the salt form of the tablet. It contains a trivial amount of potassium and it is not the reason ARBs raise potassium levels. The reason is the aldosterone effect described further down.
How fast does losartan lower blood pressure?
Faster than people expect at the start and slower than they expect overall. Both halves of that sentence cause trouble.
The first drop arrives within about six hours of the first tablet, because receptor blockade begins as soon as the drug reaches the bloodstream. You will not feel it. Some people notice a slight woolliness on standing during the first week, and that fades as the body recalibrates its reflexes to the new set point.
The full effect of any given dose takes three to six weeks, and the prescribing information says so explicitly. The delay is not absorption. Blocking the receptor immediately stops the vessel-tightening signal, and the rest of the machinery has to catch up: aldosterone falls, the kidney gradually shifts its sodium handling, total body fluid re-equilibrates, and vessel walls that have been held under tension for years slowly relax. Those are slow biological processes with time constants measured in weeks.
This is the single biggest source of unnecessary drug switching. Someone starts losartan, checks their pressure on day four, sees 148/92 where it was 154/96, and concludes the tablet is useless. What they have measured is a drug one-third of the way through its onset, using a method with its own noise. A single reading can vary by 10 mmHg for reasons that have nothing to do with medication, which is why how you take the reading matters as much as when. Take a week of paired morning and evening readings before starting, then repeat the same week four to six weeks in, and compare the averages. Anything less is guesswork.
Missing one dose does not undo the progress. Losartan is the shortest acting sartan and its active metabolite still covers most of a day, so a forgotten tablet produces a modest rise. Missing several in a row erodes control. If the hours before your next dose consistently read higher, that is a conversation about the timing of blood pressure tablets.
Side effects of losartan, ranked by how often they actually happen
ARBs are among the better tolerated drug classes in medicine, and in placebo-controlled trials the side effect rate is close to the placebo rate for most complaints. That does not mean the list is empty.
| Effect | How common | What to do about it |
|---|---|---|
| Dizziness or lightheadedness on standing | The most frequent complaint, usually in the first two weeks | Stand up slowly. Report it if it persists past two weeks or causes near-fainting. |
| Raised blood potassium | Common enough that it is tested for routinely | Blood test after starting. Avoid potassium supplements and salt substitutes unless told otherwise. |
| Small rise in creatinine | Expected, and usually a sign the drug is doing its job in the kidney | A modest rise is tolerated. A large one triggers investigation. |
| Fatigue | Uncommon, and far less than with beta blockers | Often settles. Worth mentioning at review. |
| Headache | Uncommon, usually early | Generally passes. Avoid reaching for ibuprofen as the fix. |
| Muscle cramps or back pain | Uncommon | Check potassium is not the culprit in either direction. |
| Nasal congestion or sinus symptoms | Uncommon | Note that many decongestants raise blood pressure. |
| Dry cough | Rare, at roughly the placebo rate | If a cough starts, look for another cause before blaming the ARB. |
| Very low blood pressure | Rare, more likely if dehydrated or on a strong diuretic | Sit or lie down, seek advice, and check the reading. |
| Angioedema | Very rare | Swelling of lips, tongue or throat is an emergency. Call for help immediately. |
Compare that list with what other classes bring and the appeal becomes obvious. Losartan does not cause the ankle swelling that trips up so many people on amlodipine and the calcium channel blockers. It does not slow the heart or blunt exercise capacity the way metoprolol and the beta blockers can. It does not send you to the bathroom the way a thiazide does in the first weeks. What it does bring is a potassium and kidney monitoring requirement, and one absolute rule about pregnancy.
Dizziness is worth separating from lightheadedness. A brief swim in the head on getting out of a chair, in week one, is the circulation adjusting. Persistent unsteadiness, or a spell where the world goes gray, is a different signal and needs a reading taken sitting and then standing. Dizziness on blood pressure medication has several possible causes and only some of them mean the dose is wrong.
Potassium, kidneys, pregnancy and the interactions that matter
Every drug that blocks this hormone system inherits the same three vulnerabilities: potassium, kidney perfusion, and the fetus. Losartan is no exception, and neither is valsartan.
Potassium
Aldosterone is the hormone that tells the kidney to keep sodium and dump potassium. Block angiotensin II at the receptor and aldosterone falls, so less potassium leaves the body. In someone with healthy kidneys and no other contributors, the rise is small and harmless. Stack contributors and it stops being small. The list that matters: potassium supplements, potassium-sparing diuretics such as spironolactone, eplerenone, amiloride and triamterene, the antibiotic trimethoprim, and salt substitutes, which are usually potassium chloride sold as a heart-healthy swap. That last one catches people out constantly, since it looks like a sensible move for anyone reading about cutting sodium. Ordinary food is a different matter: normal amounts of fruit and vegetables are rarely the problem, so the question of bananas has a reassuring answer for anyone with normal kidney function, and a more careful one for anyone without.
The kidney and the triple whammy
Angiotensin II tightens the vessel leaving each filtering unit of the kidney, which is how the kidney maintains filtration pressure when blood flow drops. Block it and that back-pressure eases, filtration falls slightly, and creatinine ticks up. A modest rise on starting is expected and generally accepted. It is also why three particular drug groups together are dangerous. An ARB or ACE inhibitor, plus a diuretic, plus an NSAID such as ibuprofen or naproxen, removes three of the kidney’s compensation mechanisms at once, and acute kidney injury can follow within days, especially during a bout of vomiting, diarrhea or fever. Clinicians call it the triple whammy. Anyone taking losartan should read what ibuprofen does to blood pressure and kidneys before treating a headache casually, and should know which pharmacy shelf products interact with blood pressure treatment.
Pregnancy
This one is absolute. ARBs and ACE inhibitors are contraindicated throughout pregnancy. The developing fetal kidney depends on angiotensin II signaling, and blocking it causes reduced amniotic fluid, skull and limb deformity, kidney failure and death. Exposure in the second and third trimesters is the most damaging, and the drugs are avoided from the first as a matter of course. Anyone of childbearing age starting losartan should be told this plainly and offered a plan. If a pregnancy is discovered while on treatment, the prescription is changed to an agent with a pregnancy safety record, quickly and under supervision, because untreated high blood pressure in pregnancy is dangerous in its own right. Blood pressure changes across pregnancy are their own subject.
The rest of the interaction list
Lithium levels rise when an ARB is added, so lithium monitoring tightens. The direct renin inhibitor aliskiren should not be combined with an ARB in people with diabetes. Alcohol adds its own blood pressure effects on top, and heavy drinking undermines control regardless of the tablet, as the alcohol and blood pressure picture shows. Decongestants in cold and flu remedies push pressure the other way, which is why night-time cold medicines deserve a label check. Sedating and opioid painkillers have their own effects on circulation, covered in the piece on codeine and blood pressure. And stopping a blood pressure drug without supervision is its own hazard, which the article on whether you can stop taking blood pressure tablets deals with at length. Beta blockers and clonidine in particular cause rebound surges when halted abruptly.
The uric acid quirk that makes losartan slightly special
Losartan does one thing no other ARB does to any useful degree. It lowers serum uric acid.
The mechanism sits in the kidney tubule. A transporter called URAT1 reabsorbs uric acid from the filtrate back into the blood, salvaging most of what the kidney filters out. The losartan molecule itself, the parent drug before the liver converts it, inhibits that transporter. Less uric acid gets reclaimed, more leaves in the urine, and the blood level falls. The effect is modest, in the region of a few percent to around ten percent, and it appears at ordinary doses. Curiously, the active metabolite that does most of the blood pressure work has little of this effect, so the two properties are carried by different halves of the same tablet’s life cycle.
Why does that matter? Because high blood pressure and gout travel together, and several of the drugs used for one make the other worse. Thiazide and loop diuretics raise uric acid quite reliably, and a gout flare after starting a water tablet is a familiar story. So for someone who has high blood pressure and a history of gout, losartan has a small argument in its favor that none of its siblings can make. The person who most benefits from that argument is the one who needs a diuretic in the mix as well, since the losartan can offset a little of what the diuretic does to urate.
Keep the size of it in proportion. Losartan is no substitute for allopurinol, it will not abort a flare, and the urate reduction is too small to lean on as therapy. Call it a free side benefit when the drug was going to be prescribed anyway. Whether it improves cardiovascular outcomes remains open, and the evidence there is suggestive at best.
The valsartan and losartan recalls, stated plainly
If you searched this drug and hit a wall of recall headlines, here is the factual version without the alarm.
Starting in July 2018, regulators in the United States, Europe and elsewhere recalled batches of valsartan after nitrosamine impurities were found in the active ingredient. The first was NDMA, a probable human carcinogen. A second, NDEA, turned up shortly after. The impurities traced back to a change in the chemical manufacturing process at certain overseas ingredient plants, where a particular solvent route and recovered solvents allowed the nitrosamines to form. Over the following months the investigation widened, and some batches of irbesartan and, in 2019, some batches of losartan were recalled for related impurities.
Four points are worth holding on to. The recalls affected specific lots from specific manufacturers, not the drugs themselves and not the whole class, and large volumes on the market were never implicated. Regulators set strict intake limits and required testing, and the affected product left supply years ago. The estimated excess cancer risk was small in absolute terms, calculated over years of daily exposure at the highest contaminated levels found. And the part that got lost in the coverage: the FDA told patients not to stop their medicine before getting a replacement, because untreated high blood pressure was the greater danger by far.
Today’s supply is tested to those limits. If you want certainty about a specific bottle, your pharmacist can check the manufacturer and lot number against the published recall lists in a minute or two. That is a reasonable thing to ask and a bad reason to skip doses. Untreated hypertension is a leading contributor to stroke risk, and no theoretical impurity risk comes close to it.
Just been prescribed losartan? Do these six things
None of this is medical advice about your dose. It is the practical scaffolding that turns a prescription into a measurable result.
Get a baseline before the first tablet, if you can
Seven days of paired readings, morning and evening, seated and rested. Without one you have nothing to compare the six-week number against. If you have already started, take it anyway and treat it as week one, then feed the averages into the mean arterial pressure calculator for a single figure to track.
Book the blood test and keep it
Potassium and kidney function, typically a week or two after starting and after any dose change. This is the appointment people skip because they feel fine, and feeling fine tells you nothing about a potassium level. It is also how a creatinine rise gets caught while it is still trivial.
Write down every other product you take
Prescriptions, pharmacy purchases, supplements, protein powders, salt substitutes, herbal preparations. Hand the list to your pharmacist and ask specifically about potassium and about anti-inflammatories. Interactions with antidepressants, erectile dysfunction drugs and GLP-1 medications all have their own considerations, and the pharmacist is the right person to check them.
Give it six weeks before you judge it
Not four days. Not two weeks. Six weeks of consistent daily dosing, then a fresh week of readings taken the same way as the baseline. Compare averages against averages. If you are chasing a target, know which one you are chasing, since the 130/80 threshold and the older 140/90 line are both in use depending on where you live and who is treating you.
Keep doing the non-drug work
Sodium reduction, alcohol moderation, weight, sleep and exercise all keep working while the tablet works, and they compound. Losing weight and training regularly can each move the numbers enough to change what dose you need. Diet changes are slower but they hold.
Report the specific things, ignore the vague ones
Persistent dizziness, fainting, swelling of the face or tongue, muscle weakness, palpitations, a sharp fall in urine output, or a pregnancy. Those get a call. A mild headache in week one usually does not, though nothing stops you asking.
When to worry
Being on treatment does not make a high reading safe. Two situations need action, and they need different action.
A reading above 180 systolic and/or above 120 diastolic is a hypertensive crisis. If it comes with chest pain, breathlessness, weakness on one side, trouble speaking, a change in vision or a sudden severe headache, call emergency services immediately. Do not wait for a repeat reading, do not take an extra tablet, and do not drive yourself to the hospital. If the number is that high with no symptoms at all, rest quietly for five minutes and measure again, and if it stays there, contact your doctor the same day. The danger thresholds are worth knowing before you need them.
The opposite problem also exists. Pressure dropping too far on treatment shows up as lightheadedness on standing, unusual fatigue, blurred vision or a faint. A reading around 90/60 in someone who normally runs at 140 is a bigger deal than the same number in someone who has always lived there. Sitting persistently near 100/70 on medication, with symptoms, is a dose conversation and not a reason to stop taking anything on your own.
Then the specifics of this class. Swelling of lips, tongue or throat, or trouble breathing or swallowing, is an emergency without exception. Muscle weakness with palpitations can signal a high potassium level and needs a same-day blood test. A sharp drop in urine output, or rapid swelling and weight gain, points at the kidney. If you catch a stomach bug with vomiting or diarrhea, ask whether to pause the ARB and any diuretic, since dehydration is when the kidney copes worst with the blockade.
Common mistakes with losartan
Judging the drug in the first two weeks
The commonest error by a distance. Three to six weeks is the published figure, and people give it three days on a monitor they have never validated. If your readings jump around, look at technique before you look at the tablet, because timing and conditions shift a reading more than most people believe.
Switching to a potassium salt substitute
It feels like a healthy move and it is the single most predictable way to push potassium into dangerous territory on an ARB. Cut sodium by cutting processed food instead.
Treating every ache with ibuprofen
Occasional use in a healthy person is one thing. Regular use alongside an ARB and a diuretic is the combination that lands people in hospital with kidney injury. Ask the pharmacist which painkiller suits your situation.
Assuming a cough means the ARB is at fault
This one runs backwards from the usual worry. ARBs cough at placebo rates, so a new cough on losartan is more likely to be a virus, reflux, asthma or an unrelated drug. Check whether an ACE inhibitor is still on the list somewhere.
Stopping because the numbers came good
Normal readings on treatment mean the treatment is working. Stopping returns the pressure to where it was within weeks, usually silently, since high blood pressure rarely announces itself. Any change to a regimen belongs with the prescriber.
Expecting one tablet to do the whole job
Roughly half of people need two or more agents to reach target. Adding a small dose of a second class usually beats pushing one drug to its maximum, and it produces fewer side effects doing it.
The bottom line
Losartan is a blood pressure medicine, an ARB, and a good one for the right person. It holds the door shut on the receptor angiotensin II needs, relaxing arteries and stopping the kidney hoarding sodium, and it reaches full strength in three to six weeks. It leaves the enzyme that clears bradykinin alone, so the dry cough does not follow, and that single fact drives an enormous number of switches from lisinopril. Against ACE inhibitors it lowers pressure about equally with about the same cardiovascular results and better tolerability, so the choice turns on side effects, kidney numbers and cost.
The safety rules are not optional. No pregnancy, no casual potassium, no routine pairing with an ACE inhibitor, and real caution with anti-inflammatories. Get the blood test. Track the numbers properly instead of relying on the occasional reading at the pharmacy, and put them through the mean arterial pressure tool so you can see the trend that individual readings bury. If you want to know what target you are aiming at, start with what counts as a good number.
More on drugs, readings and everything around them sits in the blood pressure section, and the tools themselves live in the health calculators collection. If you are new to any of this, the site is built around the idea that you should be able to check a number yourself and understand what it means, and the practical lowering guide is the place to go next.
Questions people ask
Is losartan a blood pressure pill?
It is, and it holds two other licensed jobs alongside that one: slowing kidney damage in type 2 diabetes when protein leaks into the urine, and cutting stroke risk in hypertensive patients whose heart wall has thickened. All three run off the same receptor blockade. If you were handed a prescription without explanation, the reason is almost always the pressure.
Is losartan good for high blood pressure?
For a large share of people, yes. Guidelines list its class among the first choices for new treatment, its side effect burden is light, it costs very little as a generic, and it protects kidneys in diabetes. It suits some people poorly: anyone pregnant or planning to be, anyone whose potassium already runs high, anyone with narrowing of both renal arteries. Suitability is a per-person judgment your prescriber makes from your bloods.
How does losartan work to lower blood pressure?
Think of a hormone that needs a keyhole. Angiotensin II is a powerful squeezing signal, and it only works when it fits into the AT1 keyhole on the muscle of your artery walls. Losartan plugs that keyhole. The hormone keeps circulating with nowhere to act, the arterial muscle stops being told to contract, and the adrenal signal to hoard salt weakens at the same time. Wider tubes and less retained fluid means lower pressure.
How quickly does losartan lower blood pressure?
Something starts on day one. Peak effect from a single tablet lands roughly six hours after swallowing it, and there is nothing to feel. The number you would measure that evening is a fraction of where the drug eventually settles, so treat a first-week reading as an early signal.
How long does losartan take to reach full effect?
Between three and six weeks at a steady dose. Receptor blocking is instant; fluid and sodium rebalancing is not, and the arterial wall takes time to give up tone it has held for years. Practical version: mark six weeks on a calendar, take readings the same way at the same times, and review the averages then.
What are the side effects of losartan blood pressure medicine?
Feeling swimmy when you stand is the one people notice, usually early and usually passing. Beyond that: tiredness, headache, cramps, a rise in blood potassium and a small climb in creatinine that shows up only on a blood test. Serious reactions are rare. The ones to act on immediately are facial or throat swelling, fainting, and muscle weakness paired with an irregular heartbeat.
Is valsartan for blood pressure, and is it a good one?
Yes on both counts. Valsartan treats hypertension, heart failure and the period after a heart attack, and it is one of the most studied members of the family. Its edge over losartan is duration, since one daily tablet reliably covers the full day. Losartan’s edge is the urate effect. Neither beats the other on pressure lowering by any margin you would notice at home.
How does valsartan lower blood pressure, and does it differ from losartan?
Identical route: it occupies the AT1 receptor so the constriction signal cannot land. The differences are pharmacological housekeeping. Valsartan is active as swallowed, while losartan relies on the liver to convert it into its stronger form, so anyone with significant liver impairment may be handled differently. Valsartan also appears in the combination heart failure tablet paired with sacubitril, which losartan does not.
Can I take losartan and lisinopril at the same time?
Outside specialist care, no. Doubling up on the same hormone pathway was tested in a very large trial and it delivered nothing extra while producing more fainting, more kidney trouble and more potassium problems. If both names appear on your repeat prescription, that is worth flagging to your pharmacist today. It is occasionally deliberate under a specialist’s eye, and far more often a leftover from an incomplete switch.
Can losartan give me a dry cough?
Rarely. In trials the cough rate on ARBs sits level with placebo, which is the main reason people get moved onto them. So if a tickly cough starts after you begin losartan, the tablet is a weak suspect. Look at a recent viral infection, reflux, allergy, asthma, or whether an older prescription from the ACE inhibitor family is still being dispensed alongside it.
Does losartan damage the kidneys?
The opposite, in most cases. It is used specifically to protect kidneys in diabetes with proteinuria. A small creatinine rise when you start is a predictable consequence of easing pressure inside the filtering units, and it is accepted. Kidney harm becomes a genuine risk in narrow circumstances: severe dehydration, narrowing of both renal arteries, or the combination of an ARB with a diuretic and an anti-inflammatory during an acute illness.
Can I take ibuprofen while I am on losartan?
Ask your pharmacist about your particular situation. As a rule, anti-inflammatories work against ARBs by encouraging sodium retention and constricting the vessel feeding the kidney filter, so blood pressure control slips and kidney risk rises. The risk climbs sharply when a diuretic is in the mix too. Acetaminophen is often suggested as the alternative, and topical anti-inflammatory gels reach the bloodstream far less than tablets do.
Why can I not use a salt substitute?
Because the substitute is usually potassium chloride, and losartan already pushes potassium upward by turning down aldosterone. Together they can lift the level far enough to disturb heart rhythm, and there is often no warning sign beforehand. Reduce sodium by eating less packaged and restaurant food. If a substitute genuinely appeals to you, clear it with the clinician who monitors your bloods first.
Are losartan and valsartan still being recalled?
No. The nitrosamine recalls ran from 2018 into 2019 and covered particular batches from particular ingredient suppliers, and those lots left the supply chain long ago. Testing requirements and impurity limits have applied to manufacturers ever since. A pharmacist can match the lot number on your bottle against published lists if you want confirmation, and skipping doses while you wonder is the more harmful choice.
Related reading
Medical disclaimer and sources
This article is information, not medical advice
Nothing here is a recommendation about your dose, your brand or your treatment plan. No dosing guidance is given anywhere in this article on purpose. Do not start, stop, switch or skip a prescribed blood pressure medicine on the strength of anything you read online, including this page. Stopping treatment without supervision is dangerous, and some drugs, beta blockers and clonidine especially, cause a rebound surge in pressure when they are halted abruptly. Talk to your doctor or pharmacist about your own situation.
A reading above 180 systolic and/or above 120 diastolic is a hypertensive crisis. Together with chest pain, breathlessness, one-sided weakness, difficulty speaking, vision change or a sudden severe headache, call emergency services immediately. Do not wait and do not drive yourself. Swelling of the lips, tongue or throat while taking any drug in this family is also an emergency.
American Heart Association
Types of blood pressure medications, covering ARBs, ACE inhibitors and the other first-line classes.
CDC
High blood pressure treatment, the plain-language overview of medication and lifestyle management.
